These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 21211642

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults.
    Nelson HS, Nolte H, Creticos P, Maloney J, Wu J, Bernstein DI.
    J Allergy Clin Immunol; 2011 Jan; 127(1):72-80, 80.e1-2. PubMed ID: 21211643
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness of grass allergen tablet (GRAZAX) for the prevention of seasonal grass pollen induced rhinoconjunctivitis - a Northern European perspective.
    Bachert C, Vestenbaek U, Christensen J, Griffiths UK, Poulsen PB.
    Clin Exp Allergy; 2007 May; 37(5):772-9. PubMed ID: 17456225
    [Abstract] [Full Text] [Related]

  • 5. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S.
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Allergy immunotherapy tablet: Grazax® for the treatment of grass pollen allergy.
    Senna GE, Calderon M, Milani M.
    Expert Rev Clin Immunol; 2011 Jan; 7(1):21-7. PubMed ID: 21162646
    [Abstract] [Full Text] [Related]

  • 8. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults.
    Nolte H, Hébert J, Berman G, Gawchik S, White M, Kaur A, Liu N, Lumry W, Maloney J.
    Ann Allergy Asthma Immunol; 2013 Jun; 110(6):450-456.e4. PubMed ID: 23706715
    [Abstract] [Full Text] [Related]

  • 9. Effect of AIT in children including potential to prevent the development of asthma.
    Valovirta E.
    Allergy; 2011 Jul; 66 Suppl 95():53-4. PubMed ID: 21668856
    [Abstract] [Full Text] [Related]

  • 10. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G, Hurley C, Turcanu V, Lack G.
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [Abstract] [Full Text] [Related]

  • 11. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis.
    Didier A, Malling HJ, Worm M, Horak F, Jäger S, Montagut A, André C, de Beaumont O, Melac M.
    J Allergy Clin Immunol; 2007 Dec; 120(6):1338-45. PubMed ID: 17935764
    [Abstract] [Full Text] [Related]

  • 12. [Vaccination with allergens in children].
    Demoly P, Dhivert-Donnadieu H, Bousquet J.
    Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
    [Abstract] [Full Text] [Related]

  • 13. Monoid sublingual immunotherapy.
    Palma-Carlos AG, Santos AS, Branco-Ferreira M, Pregal AL, Palma-Carlos ML.
    Eur Ann Allergy Clin Immunol; 2006 Mar; 38(3):87-9. PubMed ID: 16752693
    [Abstract] [Full Text] [Related]

  • 14. Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children.
    Ibañez MD, Kaiser F, Knecht R, Armentia A, Schöpfer H, Tholstrup B, Bufe A.
    Pediatr Allergy Immunol; 2007 Sep; 18(6):516-22. PubMed ID: 17680910
    [Abstract] [Full Text] [Related]

  • 15. Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial.
    Kleine-Tebbe J, Ribel M, Herold DA.
    Allergy; 2006 Feb; 61(2):181-4. PubMed ID: 16409193
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults.
    Creticos PS, Maloney J, Bernstein DI, Casale T, Kaur A, Fisher R, Liu N, Murphy K, Nékám K, Nolte H.
    J Allergy Clin Immunol; 2013 May; 131(5):1342-9.e6. PubMed ID: 23622121
    [Abstract] [Full Text] [Related]

  • 18. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage.
    Durham SR, Riis B.
    Allergy; 2007 Aug; 62(8):954-7. PubMed ID: 17620075
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of sublingual immunotherapy in children.
    Bufe A.
    Drugs Today (Barc); 2008 Dec; 44 Suppl B():61-3. PubMed ID: 19221622
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of respiratory allergy with allergy immunotherapy tablets.
    Bachert C.
    Allergy; 2011 Jul; 66 Suppl 95():57-9. PubMed ID: 21668858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.